Molecular Etiology of Spinal Muscular Atrophy

脊髓性肌萎缩症的分子病因学

• 批准号: 8106711
• 负责人: A. Gregory Matera
• 金额: $ 29.48万
• 依托单位: UNIV OF NORTH CAROLINA CHAPEL HILL
• 依托单位国家: 美国
• 财政年份: 2001
• 资助国家: 美国
• 起止时间: 2001-05-01 至 2014-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8106711
• 关键词: Actins; Acute; Address; Adult; Affect; Age; Animals; Back; Behavior; Binding; Biochemical; Biological; Biological Assay; Biological Models; Bundling; Cells; Chest; Child; Childhood; Complex; Control Animal; Data; Defect; Development; Developmental Process; Disease; Drosophila genus; Embryo; Employee Strikes; Etiology; Eukaryotic Cell; Failure; Fimbrin; Functional disorder; Genes; Genetic Recombination; Genomics; Goals; Hereditary Disease; Human; Individual; Inherited; Integrase; Invertebrates; Knowledge; Lead; Learning; Location; Maintenance; Mammals; Methods; Molecular; Motor; Motor Neurons; Mus; Muscle; Muscle Fibers; Muscular Atrophy; Mutation; Myoblasts; Myofibrillogenesis; Nerve; Neuromuscular Diseases; Neurons; Pathology; Pathway interactions; Patients; Pattern; Phenotype; Play; Point Mutation; Positioning Attribute; Process; Protein Isoforms; Proteins; RNA Interference; RNA Splicing; Relative (related person); Research Personnel; Role; SMN2 gene; Series; Site; Small Nuclear Ribonucleoproteins; Spinal Muscular Atrophy; Structure; Synaptic Transmission; System; Testing; Tissues; Transgenes; Transgenic Organisms; base; disease-causing mutation; early childhood; effective therapy; fly; in vivo; loss of function mutation; mRNA Precursor; migration; motor neuron degeneration; mouse model; mutant; myogenesis; nerve supply; neurogenesis; neuromuscular; novel therapeutic intervention; null mutation; overexpression; prenatal; promoter; protein complex; research study

DESCRIPTION (provided by investigator): Spinal Muscular Atrophy (SMA) is a devastating neuromuscular disorder, caused by mutation of the human survival motor neuron 1 (SMN1) gene. Patients with SMA typically die early in childhood. Reduced levels of SMN protein cause the disease; complete loss of SMN expression results in prenatal lethality. The underlying cause of the SMA phenotype is not yet known. SMN protein is part of a large, oligomeric complex that plays an essential role in small nuclear ribonucleoprotein (snRNP) assembly, a process central to all eukaryotic cells. There is also evidence that SMN carries out additional tissue-specific functions in neurons and muscles. However, the molecular details of these tissue-specific functions of SMN are unclear. Thus learning more about SMN's role in neuromuscular development and function is essential for our understanding of SMA pathology. The major objective of this proposal is to obtain detailed knowledge of the role played by the SMN protein complex in the development and function of the neuromusculature, using Drosophila and mammalian model systems. To address this objective we have defined the following three Specific Aims: (1) We will assay the relative contributions of individual SMA-causing mutations on the general versus the tissue-specific functions of SMN in Drosophila. (2) We will identify the cellular and molecular mechanisms that lead to the observed muscle defects caused by reduced Drosophila SMN expression. (3) We will bring the findings from the first two Aims back into the mouse system through the use of specific transgenes and molecular assays. The combined data will elucidate the molecular, cellular and developmental biological consequences of reduced SMN expression and lead to a better understanding of the etiology of Spinal Muscular Atrophy. PUBLIC HEALTH RELEVANCE: Spinal Muscular Atrophy (SMA) is a common genetic disease that strikes one in 6,000-8,000 young children; most of whom die before reaching the age of two years. The responsible gene has been identified, but the precise role of the gene product is not known. To aid in the development of an effective treatment for SMA, this proposal seeks to understand the underlying basis of the disease.

描述（由研究者提供）：脊髓性肌萎缩症（SMA）是一种破坏性神经肌肉疾病，由人运动神经元生存1（SMN 1）基因突变引起。SMA患者通常在儿童早期死亡。SMN蛋白水平降低导致疾病; SMN表达的完全丧失导致产前致死。SMA表型的根本原因尚不清楚。SMN蛋白是一个大的寡聚复合物的一部分，在小核核糖核蛋白（snRNP）组装中发挥重要作用，这是所有真核细胞的核心过程。还有证据表明，SMN在神经元和肌肉中执行额外的组织特异性功能。然而，SMN的这些组织特异性功能的分子细节尚不清楚。因此，了解更多关于SMN在神经肌肉发育和功能中的作用对于我们理解SMA病理学至关重要。本提案的主要目的是获得详细的知识，由SMN蛋白复合物在神经肌肉组织的发展和功能中发挥的作用，使用果蝇和哺乳动物模型系统。为了实现这一目标，我们定义了以下三个具体目标：（1）我们将分析单个SMA引起的突变对果蝇SMN的一般功能与组织特异性功能的相对贡献。(2)我们将确定细胞和分子机制，导致观察到的肌肉缺陷所造成的果蝇SMN表达减少。(3)我们将通过使用特定的转基因和分子检测将前两个目标的发现带回小鼠系统。综合数据将阐明SMN表达减少的分子，细胞和发育生物学后果，并导致更好地了解脊髓性肌萎缩症的病因。 公共卫生相关性：脊髓性肌萎缩症（SMA）是一种常见的遗传性疾病，每6，000 - 8，000名幼儿中就有一人患病;其中大多数人在两岁之前死亡。负责的基因已被确定，但基因产物的确切作用尚不清楚。为了帮助开发SMA的有效治疗方法，本提案旨在了解该疾病的潜在基础。